308 related articles for article (PubMed ID: 37583694)
1. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of
Gupta PK; Jahagirdar P; Tripathi D; Devarajan PV; Kulkarni S
Front Immunol; 2023; 14():1233630. PubMed ID: 37583694
[TBL] [Abstract][Full Text] [Related]
2. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary Killing.
Lawlor C; O'Connor G; O'Leary S; Gallagher PJ; Cryan SA; Keane J; O'Sullivan MP
PLoS One; 2016; 11(2):e0149167. PubMed ID: 26894562
[TBL] [Abstract][Full Text] [Related]
4. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy.
Wang J; Sha J; Strong E; Chopra AK; Lee S
Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
[TBL] [Abstract][Full Text] [Related]
6. Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection.
Bai X; Oberley-Deegan RE; Bai A; Ovrutsky AR; Kinney WH; Weaver M; Zhang G; Honda JR; Chan ED
Respirology; 2016 Jul; 21(5):951-7. PubMed ID: 27012592
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles Released from
Alvarez-Jiménez VD; Leyva-Paredes K; García-Martínez M; Vázquez-Flores L; García-Paredes VG; Campillo-Navarro M; Romo-Cruz I; Rosales-García VH; Castañeda-Casimiro J; González-Pozos S; Hernández JM; Wong-Baeza C; García-Pérez BE; Ortiz-Navarrete V; Estrada-Parra S; Serafín-López J; Wong-Baeza I; Chacón-Salinas R; Estrada-García I
Front Immunol; 2018; 9():272. PubMed ID: 29520273
[TBL] [Abstract][Full Text] [Related]
8. Targeted depletion of BTF3a in macrophages activates autophagic pathway to eliminate Mycobacterium tuberculosis.
Rawat K; Das S; Vivek Vinod BS; Vekariya U; Garg T; Dasgupta A; Tripathi RK
Life Sci; 2019 Mar; 220():21-31. PubMed ID: 30684544
[TBL] [Abstract][Full Text] [Related]
9. Ursolic Acid Promotes Autophagy by Inhibiting Akt/mTOR and TNF-α/TNFR1 Signaling Pathways to Alleviate Pyroptosis and Necroptosis in Mycobacterium tuberculosis-Infected Macrophages.
Shen J; Fu Y; Liu F; Ning B; Jiang X
Inflammation; 2023 Oct; 46(5):1749-1763. PubMed ID: 37212951
[TBL] [Abstract][Full Text] [Related]
10. Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2 (DRAM2).
Liu G; Wan Q; Li J; Hu X; Gu X; Xu S
Cell Cycle; 2020 Nov; 19(22):3182-3194. PubMed ID: 33121314
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.
Palucci I; Matic I; Falasca L; Minerva M; Maulucci G; De Spirito M; Petruccioli E; Goletti D; Rossin F; Piacentini M; Delogu G
J Intern Med; 2018 Mar; 283(3):303-313. PubMed ID: 29205566
[TBL] [Abstract][Full Text] [Related]
12. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant
Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q
Front Immunol; 2021; 12():796677. PubMed ID: 35003120
[TBL] [Abstract][Full Text] [Related]
13. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
[TBL] [Abstract][Full Text] [Related]
14. Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy.
Hu Y; Wen Z; Liu S; Cai Y; Guo J; Xu Y; Lin D; Zhu J; Li D; Chen X
J Infect; 2020 Jun; 80(6):e19-e26. PubMed ID: 32171871
[TBL] [Abstract][Full Text] [Related]
15. Transcription Repressor Protein ZBTB25 Associates with HDAC1-Sin3a Complex in Mycobacterium tuberculosis-Infected Macrophages, and Its Inhibition Clears Pathogen by Autophagy.
Madhavan A; Arun KB; Pushparajan AR; Balaji M; Kumar RA
mSphere; 2021 Feb; 6(1):. PubMed ID: 33627504
[TBL] [Abstract][Full Text] [Related]
16. Activation of TLR7 Inhibition of Mycobacterium Tuberculosis Survival by Autophagy in RAW 264.7 Macrophages.
Bao M; Yi Z; Fu Y
J Cell Biochem; 2017 Dec; 118(12):4222-4229. PubMed ID: 28419514
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
Subbian S; Tsenova L; O'Brien P; Yang G; Koo MS; Peixoto B; Fallows D; Dartois V; Muller G; Kaplan G
PLoS Pathog; 2011 Sep; 7(9):e1002262. PubMed ID: 21949656
[TBL] [Abstract][Full Text] [Related]
18. Berbamine promotes macrophage autophagy to clear
Zhang S; Zhou X; Ou M; Fu X; Lin Q; Tao X; Wang Z; Liu A; Li G; Xu Y; Zhang G
mBio; 2023 Aug; 14(4):e0027223. PubMed ID: 37382506
[TBL] [Abstract][Full Text] [Related]
19. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
Lee HJ; Ko HJ; Kim SH; Jung YJ
PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
[TBL] [Abstract][Full Text] [Related]
20. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
